Skip to content

Drug interactions

Famotidine + Sparsentan

Severity: Moderate

Famotidine and Sparsentan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sparsentan is less soluble at higher pH, so acid-reducing agents may lower its exposure. Reduced exposure could weaken its effect on proteinuria in IgA nephropathy.

What this interaction means in plain words

Famotidine and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Famotidine belongs to Gastrointestinal Tract; Sparsentan belongs to Genitourinary.

Evidence level: Low

Why it happens

Elevated gastric pH reduces the solubility and absorption of sparsentan.

What to do

Monitor proteinuria and clinical response; consider separating doses or choosing a non-acid-suppressing alternative.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Famotidine and Sparsentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Famotidine with Sparsentan?

MediHelp rates the interaction as moderate. Famotidine and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sparsentan is less soluble at higher pH, so acid-reducing agents may lower its exposure. Reduced exposure could weaken its effect on proteinuria in IgA nephropathy.

How serious is the interaction between Famotidine and Sparsentan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor proteinuria and clinical response; consider separating doses or choosing a non-acid-suppressing alternative.

What other medicines interact with Famotidine?

MediHelp also lists interactions of Famotidine with, for example, Atazanavir, Dasatinib, Infigratinib. The full list is on the Famotidine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in